• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Health Equity: Clinical Development’s Future Framework



Thu, Aug 18, 2022 2:00 PM EDT Value for patients, value for all. Learn how today’s health equity initiatives are shaping best-in-class clinical development frameworks of the future.

Register Free: https://www.pharmexec.com/pe_w/health_equity

Event Overview:

This webinar will focus on the expanding opportunity that pharmaceutical and life sciences companies now have in understanding how social determinants are impacting the epidemiology of disease and apply this new framework into all future workstreams. New data insights are building these frameworks as organizations can now identify health conditions that are undertreated, map how different groups are affected, and determine where intervention is most effective. Prioritizing health equity within the value stream of clinical development not only ensures better patient outcomes for all patients, but ensures a sustainable framework in the understanding and targeted treatment of disease.

Key Learning Objectives:
How health equity initiatives are shaping best-in-class clinical development frameworks
Opportunities within the value stream
What data insights are available today to support health equity
How to start incorporating health equity initiatives into your designs
How to partner with patient advocacy groups as a force multiplier for greater impact

Who Should Attend:
Life sciences professionals with an interest in how health equity initiatives are being prioritized through the clinical development value streams and how to start incorporating these new data insights today


Kwame Marfo
MSI Lead for Clinical Development
Komodo Health

Kwame is the Market Strategy and Innovation Lead for Clinical Development at Komodo Health. He has 15+ years of experience in the healthcare industry, working in strategy and operations leadership roles across manufacturing technical operations, commercial, and R&D. Prior to Komodo, Kwame served as a Director of Insights and Analytics for Roche/Genentech’s Global Clinical Operations. Kwame graduated with a BS in Chemical Engineering from Stanford University and an MBA in Corporate Strategy and Market Analysis from the University of California, Berkeley.

Learn More About Kwame’s Work:
Diversity in Clinical Trials: A Regulatory Imperative
Putting Data to Work: How RWE Can Deliver Speed, Insights, and Value for Clinical Trials
Generate Richer Insights Before and After the Trial With Real-World Data

Register Free: https://www.pharmexec.com/pe_w/health_equity

Related Content